AFJKU Aimei Health Technology Co., Ltd - Unit
$54.82
Price · May 21, 2026
Fundamentals as of May 4, 2026
52W Range
$8–$80
65% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-30.6%
Net Profit Margin
—
AFJKU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$54.82
Market Cap
$140M
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-30.6%
Debt/Equity
—
52W Range
$8 – $80
AFJKU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AFJKU
Peer Median
P/B
-34.6
0.9
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AFJKU
Peer Median
ROA
2.5%
3.1%
ROE
-30.6%
3.9%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AFJKU
Peer Median
Current Ratio
0.0
1.8
Quick Ratio
0.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AFJKU
Peer Median
Net Income YoY
-58.5%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AFJKU
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 5
| Metric | Trend | 2025 |
|---|---|---|
| Operating Income | $-835.8K | |
| Other Non-op | $2M | |
| Income Tax | $0 | |
| Net Income | $1M | |
| EBITDA | $-835.8K |
Balance Sheet 11
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $2.9K | |
| Current Assets | $2.9K | |
| Total Assets | $12M | |
| Accrued Liabilities | $448.0K | |
| Current Liabilities | $3M | |
| Total Liabilities | $4M | |
| Common Stock | $213 | |
| Retained Earnings | $-4M | |
| Stockholders' Equity | $-4M | |
| Liabilities + Equity | $12M | |
| Shares Outstanding | 2,126,000 |
Cash Flow 4
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-565.1K | |
| Investing Cash Flow | $64M | |
| Financing Cash Flow | $-63M | |
| Net Change in Cash | $-25.3K |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 2.5% | |
| ROE | -30.6% |
Liquidity & Solvency 2
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.0 | |
| Quick Ratio | 0.0 |
Growth Rates 1
| Metric | Trend | 2025 |
|---|---|---|
| Net Income YoY | -58.5% |
Valuation (TTM) 4
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $1M | |
| Market Cap | $140M | |
| P/B | -34.6 | |
| P / Cash Flow | -248.3 |
Income Statement 4
| Metric | Trend | Q4 2025 |
|---|---|---|
| Operating Income | $-250.6K | |
| Other Non-op | $348.7K | |
| Income Tax | $0 | |
| Net Income | $98.1K |
Balance Sheet 11
| Metric | Trend | Q4 2025 |
|---|---|---|
| Cash & Equivalents | $2.9K | |
| Current Assets | $2.9K | |
| Total Assets | $12M | |
| Accrued Liabilities | $448.0K | |
| Current Liabilities | $3M | |
| Total Liabilities | $4M | |
| Common Stock | $213 | |
| Retained Earnings | $-4M | |
| Stockholders' Equity | $-4M | |
| Liabilities + Equity | $12M | |
| Shares Outstanding | 2,126,000 |
Cash Flow 4
| Metric | Trend | Q4 2025 |
|---|---|---|
| Operating Cash Flow | $-43.2K | |
| Investing Cash Flow | $34M | |
| Financing Cash Flow | $-34M | |
| Net Change in Cash | $-50 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $1M | $3M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 0.0 | — |
| Quick Ratio | 0.0 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.